Stem Cell Transplant in Patients With Severe Sickle Cell Disease
Status:
Recruiting
Trial end date:
2026-02-15
Target enrollment:
Participant gender:
Summary
This is a prospective pilot study of matched-related donor allogeneic stem cell
transplantation in adults with severe sickle cell disease using a matched-sibling PBSC graft
with a non-myeloablative conditioning regimen (Alemtuzumab).